ACM
GHDX

Apex Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Apex Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,451
Closed -$364K – 282
2013
Q4 		$364K Sell
12,451
-361,005
-97% -$11.5M 0.01% 225
2013
Q3 		$11.4M Sell
373,456
-24,077
-6% -$805K 0.5% 66
2013
Q2 		$12.6M Buy
+397,533
New +$13.1M 0.61% 65

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Apex Capital Management's GHDX Position: Q1 2014 in Review

Apex Capital Management sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 12,451 shares — an estimated $364K sold.

Apex Capital Management first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $12.6M in Q2 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Apex Capital Management reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Apex Capital Management sold 12,451 Genomic Health, Inc. shares in Q1 2014, an estimated $364K.
  • Apex Capital Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
  • Apex Capital Management's Genomic Health, Inc. position peaked at $12.6M in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Apex Capital Management's 13F filing for Q1 2014, filed 29 Apr 2014.